XML 46 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Taxes  
Schedule of consolidated income before taxes for domestic and foreign operations

 

 

Year ended December 31,

 

 

 

2022

 

 

2021

 

Domestic

 

$

28,754

 

$

(6,201

)

Foreign

 

 

(1,294

)

 

 

(1,776

)

Total

 

$

27,460

 

$

(7,977

)

Schedule of components of (provision) for income taxes

 

 

Year ended December 31,

 

 

 

2022

 

 

2021

 

Current:

 

 

 

 

 

 

 

 

Federal

 

$

(6,753

)

 

$

373

State

 

 

(98

)

 

 

(9

)

Foreign

 

 

(53

)

 

 

(81

)

Total current

 

 

(6,904

)

 

 

283

Deferred:

 

 

 

 

 

 

 

 

Federal

 

 

1,132

 

 

1,326

State

 

 

(976

)

 

 

398

 

Foreign

 

 

165

 

 

 

302

 

Total

 

 

321

 

 

2,026

Change in valuation allowance

 

 

(321

)

 

 

(2,026

)

Total deferred

 

 


 

 

Tax benefit (provision)

 

$

(6,904

)

 

$

283

Schedule of income tax (provision) differs from that computed at the federal statutory corporate income tax rate

 

 

Year ended December 31,

 

 

 

2022

 

 

2021

 

Tax benefit (provision) at federal statutory rate

 

$

(5,768

)

 

$

1,674

 

State income tax benefit (provision), net of federal benefit

 

 

(1,093

)

 

 

335

 

Research and development tax credits

 

 

457

 

 

 

361

 

Foreign earnings or losses taxed at different rates

 

 

(68

)

 

 

(28

)

Tax rate change

 

 

(60

)

 

 

(2

)

Other

 

 

(51

)

 

 

(31

)

Change in valuation allowance

 

 

(321

)

 

 

(2,026

)

Tax benefit (provision)

 

$

(6,904

)

 

$

283

Schedule of tax effects of significant temporary differences representing net deferred tax assets and liabilities

 

 

2022

 

 

2021

 

Deferred revenue

 

$

11

 

 

$

9

 

Basis difference in intangible assets

 

 

6,604

 

 

 

1,319

 

Inventory reserve

 

 

2,258

 

 

 

2,377

 

Net operating loss carryforwards

 

 

3,075

 

 

 

7,121

 

Research and development tax credits

 

 

48

 

 

 

1,579

 

Accrued expenses

 

 

120

 

 

 

43

 

Stock-based compensation

 

 

215

 

 

 

308

 

Allowance for sales returns and doubtful accounts

 

 

81

 

 

 

83

 

Difference in property and equipment basis

 

 

(83

)

 

 

(124

)
Convertible debt

(110)

(112)
Capitalized research expenditure

922



Other

 

 

364

 

 

 

581

 

Total net deferred income tax asset

 

 

13,505

 

 

 

13,184

 

Less: Valuation allowance

 

 

(13,505

)

 

 

(13,184

)

Net deferred income tax asset (liability)

 

$

 

 

$

 

Schedule of reconciliation of the beginning and ending amount of liabilities associated with uncertain tax positions

 

 

Year ended December 31,

 

 

 

2022

 

 

2021

 

Balance - beginning of year

 

$

895

 

 

$

861

 

Additions based on tax positions related to the current year

 

 

75

 

 

 

61

 

Additions for tax positions of prior years

 

 

 

 

 

 

Reductions for tax positions of prior years

 

 


 

 

Settlements

 

 

 

 

(20

)

Lapse in statutes of limitations 

 

 

(8)

 

 

(7

)

Uncertain tax positions, ending balance

 

$

962

 

 

$

895